{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:19:24Z","timestamp":1783487964118,"version":"3.55.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.beem.2017.02.002","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T20:33:37Z","timestamp":1487795617000},"page":"49-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Focus on growth hormone deficiency and bone in adults"],"prefix":"10.1016","volume":"31","author":[{"given":"Nicholas A.","family":"Tritos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2017.02.002_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/223403a0","article-title":"Effect of growth hormone on skeletal mass in adult dogs","volume":"223","author":"Harris","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.beem.2017.02.002_bib2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/281544a0","article-title":"Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone","volume":"281","author":"Goeddel","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.beem.2017.02.002_bib3","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency","volume":"321","author":"Salomon","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2017.02.002_bib4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","article-title":"Beneficial effects of growth hormone treatment in GH-deficient adults","volume":"1","author":"Jorgensen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2017.02.002_bib5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.med.54.101601.152147","article-title":"Growth hormone therapy in adults","volume":"54","author":"Cummings","year":"2003","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.beem.2017.02.002_bib6","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl A","key":"10.1016\/j.beem.2017.02.002_bib7","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ghir.2004.03.006","article-title":"Reciprocal interactions between the GH axis and sleep","volume":"14","author":"Van Cauter","year":"2004","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.beem.2017.02.002_bib8","first-page":"553","article-title":"Interrelations between sleep and the somatotropic axis","volume":"21","author":"Van Cauter","year":"1998","journal-title":"Sleep"},{"key":"10.1016\/j.beem.2017.02.002_bib9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrendo.2010.123","article-title":"The growth hormone receptor: mechanism of activation and clinical implications","volume":"6","author":"Brooks","year":"2010","journal-title":"Nat Rev Endocrinol"},{"issue":"Suppl A","key":"10.1016\/j.beem.2017.02.002_bib10","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ghir.2006.03.005","article-title":"Endocrinology\u2013the way we were: a personal history of somatomedin","volume":"16","author":"Daughaday","year":"2006","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.beem.2017.02.002_bib11","first-page":"825","article-title":"A\u00a0hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in\u00a0vitro","volume":"49","author":"Salmon","year":"1957","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.beem.2017.02.002_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2008-0027","article-title":"Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects","volume":"30","author":"Moller","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2017.02.002_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1677\/JOE-07-0012","article-title":"Spatial and temporal regulation of GH-IGF-related gene expression in growth plate cartilage","volume":"194","author":"Parker","year":"2007","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.beem.2017.02.002_bib14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF00298723","article-title":"Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in\u00a0vitro","volume":"52","author":"Kassem","year":"1993","journal-title":"Calcif Tissue Int"},{"issue":"Suppl 5","key":"10.1016\/j.beem.2017.02.002_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000191328","article-title":"The action of GH\/IGF-I\/IGFBP in osteoblasts and osteoclasts","volume":"48","author":"Chihara","year":"1997","journal-title":"Horm Res"},{"key":"10.1016\/j.beem.2017.02.002_bib16","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1210\/endo-128-3-1459","article-title":"Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH","volume":"128","author":"Barnard","year":"1991","journal-title":"Endocrinology"},{"issue":"Suppl B","key":"10.1016\/j.beem.2017.02.002_bib17","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/S1096-6374(00)80020-9","article-title":"In\u00a0vitro studies of insulin-like growth factor I and bone","volume":"10","author":"Conover","year":"2000","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.beem.2017.02.002_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/8756-3282(94)00051-4","article-title":"Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats","volume":"16","author":"Watson","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.beem.2017.02.002_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/MPH.0b013e318266c0ef","article-title":"Human parathyroid hormone increases the mRNA expression of the IGF system and hematopoietic growth factors in osteoblasts, but does not influence expression in mesenchymal stem cells","volume":"34","author":"Lee","year":"2012","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.beem.2017.02.002_bib20","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1359\/jbmr.2002.17.9.1570","article-title":"Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone","volume":"17","author":"Bikle","year":"2002","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2017.02.002_bib21","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1210\/jcem-49-2-185","article-title":"Parathyroid function and vitamin D metabolism during human growth hormone replacement","volume":"49","author":"Gertner","year":"1979","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.002_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1530\/eje.0.1360045","article-title":"Growth hormone increases serum 1,25-dihydroxyvitamin D levels and decreases 24,25-dihydroxyvitamin D levels in children with growth hormone deficiency","volume":"136","author":"Wei","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.002_bib23","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/jbmr.5650081210","article-title":"Thyroid hormones increase insulin-like growth factor I content in the medium of rat bone tissue","volume":"8","author":"Lakatos","year":"1993","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2017.02.002_bib24","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1210\/mend-5-8-1081","article-title":"Estradiol regulation of insulin-like growth factor-I expression in osteoblastic cells: evidence for transcriptional control","volume":"5","author":"Ernst","year":"1991","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.beem.2017.02.002_bib25","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1210\/mend.15.10.0704","article-title":"Glucocorticoid suppression of IGF I transcription in osteoblasts","volume":"15","author":"Delany","year":"2001","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.beem.2017.02.002_bib26","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1172\/JCI10753","article-title":"Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5","volume":"106","author":"Sims","year":"2000","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.beem.2017.02.002_bib27","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1359\/jbmr.090226","article-title":"Serum IGF-1 determines skeletal strength by regulating subperiosteal expansion and trait interactions","volume":"24","author":"Yakar","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2017.02.002_bib28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1172\/JCI0215463","article-title":"Circulating levels of IGF-1 directly regulate bone growth and density","volume":"110","author":"Yakar","year":"2002","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.beem.2017.02.002_bib29","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1210\/endo.141.7.7585","article-title":"Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation","volume":"141","author":"Zhao","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2017.02.002_bib30","doi-asserted-by":"crossref","first-page":"44005","DOI":"10.1074\/jbc.M208265200","article-title":"Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization","volume":"277","author":"Zhang","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.beem.2017.02.002_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1677\/joe.0.1330291","article-title":"Effect of growth hormone and insulin-like growth factor-I on DNA synthesis and matrix production in rat epiphyseal chondrocytes in monolayer culture","volume":"133","author":"Ohlsson","year":"1992","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.beem.2017.02.002_bib32","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1210\/en.2006-1264","article-title":"Insulin-like growth factor-I and fibroblast growth factor, but not growth hormone, affect growth plate chondrocyte proliferation","volume":"148","author":"Hutchison","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2017.02.002_bib33","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1210\/endo.131.3.1505451","article-title":"Insulin-like growth factor-I supports formation and activation of osteoclasts","volume":"131","author":"Mochizuki","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2017.02.002_bib34","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1359\/jbmr.060610","article-title":"Role of IGF-I signaling in regulating osteoclastogenesis","volume":"21","author":"Wang","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2017.02.002_bib35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.gene.2005.07.016","article-title":"The insulin-like growth factor-I gene and osteoporosis: a critical appraisal","volume":"361","author":"Niu","year":"2005","journal-title":"Gene"},{"key":"10.1016\/j.beem.2017.02.002_bib36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1677\/joe.1.07073","article-title":"Growth hormone stimulates osteoprotegerin expression and secretion in human osteoblast-like cells","volume":"192","author":"Mrak","year":"2007","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.beem.2017.02.002_bib37","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1210\/endo.137.11.8895324","article-title":"Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production","volume":"137","author":"Renier","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2017.02.002_bib38","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1096-6374(03)00034-0","article-title":"Growth hormone enhances proinflammatory cytokine production by monocytes in whole blood","volume":"13","author":"Uronen-Hansson","year":"2003","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.beem.2017.02.002_bib39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/8756-3282(96)00069-5","article-title":"Histomorphometric analysis of bone mass and bone metabolism in growth hormone deficient adult men","volume":"18","author":"Bravenboer","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.beem.2017.02.002_bib40","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/BF03348952","article-title":"Growth hormone treatment in adults with GH deficiency: effects on new biochemical markers of bone and collagen turnover","volume":"16","author":"Sartorio","year":"1993","journal-title":"J\u00a0Endocrinol Investig"},{"key":"10.1016\/j.beem.2017.02.002_bib41","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-07-0631","volume":"157","author":"Ho","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.002_bib42","first-page":"669","article-title":"Reduced bone mineral density in patients with adult onset growth hormone deficiency","volume":"78","author":"Holmes","year":"1994","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.002_bib43","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1210\/jc.2003-030685","article-title":"Low bone mass is an infrequent feature of the adult growth hormone deficiency syndrome in middle-age adults and the elderly","volume":"89","author":"Murray","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.002_bib44","first-page":"1919","article-title":"Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism","volume":"84","author":"Colao","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.002_bib45","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1210\/jc.2010-2662","article-title":"Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysis","volume":"96","author":"Tritos","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.002_bib46","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1530\/eje.0.1370240","article-title":"Increased fracture frequency in adult patients with hypopituitarism and GH deficiency","volume":"137","author":"Rosen","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.002_bib47","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.0300-0664.2001.01464.x","article-title":"Fracture risk is increased in patients with GH deficiency or untreated prolactinomas\u2013a case-control study","volume":"56","author":"Vestergaard","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2017.02.002_bib48","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1359\/jbmr.2001.16.2.398","article-title":"The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density","volume":"16","author":"Wuster","year":"2001","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2017.02.002_bib49","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.060112","article-title":"Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy","volume":"21","author":"Mazziotti","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"issue":"Suppl 2","key":"10.1016\/j.beem.2017.02.002_bib50","first-page":"327","article-title":"Acquisition of bone mass in normal individuals and in patients with growth hormone deficiency","volume":"16","author":"Baroncelli","year":"2003","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"Suppl 6","key":"10.1016\/j.beem.2017.02.002_bib51","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1515\/jpem-2000-s604","article-title":"Growth and hormone deficiency and peak bone mass","volume":"13","author":"Bouillon","year":"2000","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.002_bib52","first-page":"1344","article-title":"Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency","volume":"76","author":"O'Halloran","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.002_bib53","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1210\/jc.2004-0054","article-title":"Bone status and fracture prevalence in Russian adults with childhood-onset growth hormone deficiency","volume":"89","author":"Bouillon","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.002_bib54","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1210\/jcem-18-8-901","article-title":"Treatment of a pituitary dwarf with human growth hormone","volume":"18","author":"Raben","year":"1958","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.002_bib55","first-page":"3352","article-title":"Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study","volume":"81","author":"Hansen","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.002_bib56","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2013-3921","article-title":"Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis","volume":"99","author":"Barake","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.002_bib57","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2265.2004.01935.x","article-title":"Growth hormone replacement in adults and bone mineral density: a systematic review and meta-analysis","volume":"60","author":"Davidson","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2017.02.002_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/EJE-11-0558","article-title":"Body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis","volume":"166","author":"Hazem","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.002_bib59","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/cen.12493","article-title":"Effects of up to 15 years of recombinant human GH (rhGH) replacement on bone metabolism in adults with growth hormone deficiency (GHD): the Leiden Cohort Study","volume":"81","author":"Appelman-Dijkstra","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2017.02.002_bib60","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/EJE-11-1072","article-title":"Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency","volume":"166","author":"Elbornsson","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.002_bib61","first-page":"3956","article-title":"Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults","volume":"84","author":"Cook","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"Suppl 4","key":"10.1016\/j.beem.2017.02.002_bib62","first-page":"1273","article-title":"Growth hormone and estrogen: a clinician's approach","volume":"17","author":"Cook","year":"2004","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.002_bib63","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/cen.12132","article-title":"Predictors of the effects of 4 years of growth hormone replacement on bone mineral density in patients with adult-onset growth hormone deficiency - a KIMS database analysis","volume":"79","author":"Tritos","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2017.02.002_bib64","first-page":"257","article-title":"Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density","volume":"66","author":"Colson","year":"2006","journal-title":"Horm Res"},{"key":"10.1016\/j.beem.2017.02.002_bib65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1530\/EJE-12-0070","article-title":"A\u00a0longer interval without GH replacement and female gender are associated with lower bone mineral density in adults with childhood-onset GH deficiency: a KIMS database analysis","volume":"167","author":"Tritos","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.002_bib66","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/EJE-08-0436","article-title":"Treatment for 24 months with recombinant human growth hormone has a beneficial effect on bone mineral density in young adults with childhood-onset growth hormone deficiency","volume":"160","author":"Conway","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.002_bib67","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1210\/jc.2005-0208","article-title":"Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial","volume":"90","author":"Mauras","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.002_bib68","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1210\/jc.2003-030126","article-title":"Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study","volume":"88","author":"Shalet","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.002_bib69","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1210\/jc.2003-030204","article-title":"Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study","volume":"88","author":"Underwood","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.002_bib70","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11102-008-0101-y","article-title":"Transitioning of children with GH deficiency to adult dosing: changes in body composition","volume":"12","author":"Nguyen","year":"2009","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2017.02.002_bib71","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1359\/jbmr.070811","article-title":"Fracture incidence in GH-deficient patients on complete hormone replacement including GH","volume":"22","author":"Holmer","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2017.02.002_bib72","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S2213-8587(15)00098-4","article-title":"Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort study","volume":"3","author":"Mo","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2017.02.002_bib73","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12020-015-0738-z","article-title":"Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency","volume":"52","author":"Mazziotti","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2017.02.002_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-016-0859-z","article-title":"Skeletal health in adult growth hormone deficiency","volume":"52","author":"Tritos","year":"2016","journal-title":"Endocrine"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X17300027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X17300027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:53:08Z","timestamp":1761497588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X17300027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1521690X17300027"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2017.02.002","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Focus on growth hormone deficiency and bone in adults","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2017.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}